Product
CBD 200
1 clinical trial
1 indication
Indication
MigraineClinical trial
Cannabis for the Prophylactic Treatment of Migraine: a Randomized Double-Blind Placebo-Controlled Clinical TrialStatus: Not yet recruiting, Estimated PCD: 2026-06-01
1 clinical trial
1 indication